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OSE pregnancy rat steroid
receptors gonadotropinsAbstract The present study is designed to demonstrate the ovarian surface epithelial cells’ (OSE)
estrogen receptor a (ERa) and progesterone receptor (PR) during pregnancy and estrous cycle in
rat. Moreover, determination of the levels of plasma progesterone, estradiol, FSH and LH was also
made. The levels of plasma progesterone, estradiol, FSH and LH concentrations were determined on
days 7 (n= 5), 14 (n= 5), and 21 (n= 5) of pregnancy in three groups of rats and during the estrous
cycle (n= 5) using an ELISA kit. Immunohistochemical method for PR and ERa expressions was
also made on the ovary. During pregnancy, FSH and LH remained low except at term when LH lev-
els began to increase from 16 ng/ml to 47 ng/ml. Progesterone levels signiﬁcantly exceeded estradiol
values in all pregnant rats with a peak value of 202 ng/ml on day 14. Elevated progesterone levels
were associated negatively with LH and estradiol levels during pregnancy. The levels of estradiol
surged signiﬁcantly on day 21. Immunohistochemistry of the ovary showed low levels of OSE cells
staining positive for ERa expression. ERa positive cells were absent on day 7 and 14 of pregnancy,
only day 21 recorded a very low percentage of immunostaining (0.5%) within the nuclei of OSE cells.
On the contrary, immunostaining of PR was not observed within the nuclei of OSE cells in all groups
of study. In conclusion, these results may suggest that the progesterone effect during pregnancy
seems to be overriding the positive effect of estrogens on OSE cells. High progesterone levels may
have a direct negative effect on gonadotropin production and thereby it might inhibit events leading
to both follicular development and OSE proliferation. Understanding the factors affecting OSE pro-
liferation may help elucidating the mechanism(s) of assisted diseases such as ovarian cancer.
ª 2014 Production and hosting by Elsevier B.V. on behalf of King Saud University.1. Introduction
The mammalian ovary is a highly dynamic organ with dramat-
ically changing environment, it is covered by a single layer of
epithelial tissue; the ovarian surface epithelium (OSE). OSE
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are ﬂattened mesothelium of peritoneum separated from
underneath ovarian stroma by a basement membrane and a
connective tissue layer, tunica albuginea (Leung and Choi,
2007). OSE occupies the entire ovarian lining, and varies in
morphology from simple squamous to cuboidal to low pseudo
stratiﬁed columnar (Auersperg et al., 2001). Despite their
inconspicuous appearance, OSE participates in transporting
and exchanging nutrients and other bioactive metabolites from
the peritoneal cavity and ovary. At pre-ovulation, OSE in
proximity to rupture site undergoes apoptotic cell death and
the wound caused by ovulation is repaired by highly prolifer-
ating OSE cells from surroundings of the ruptured follicle
(Murdoch and Van Kirk, 2002). OSE cell proliferation also oc-
curs at post-ovulatory phase especially in post-menopausal
woman due to ageing of ovary; epithelial line invaginates, pro-
ducing crypts and glands, which eventually develop into cysts
within the stromal compartment (Auersperg, 2013). It has been
hypothesized that repeated cycles of ovulation-induced trauma
and repair of the OSE at the site of ovulation contribute to
malignancy, it makes the OSE susceptible to mitogenic factors
and other genotoxic radicals. There are several studies that
suggested that menstrual cycle can affect tumor growth
through the high levels of reproductive hormones (Wood
et al., 2005; Wood and Hrushesky, 2005). A host of tumorige-
netic factors, viz. cytokeratin, desmoplakin, transforming
growth factor-a (TGF-a) and receptors for estrogen, proges-
terone and epidermal growth factor (EGF) are expressed by
OSE (Li et al., 2003).
Approximately 90% of human ovarian cancers (OCs) orig-
inate from OSE. Epithelial ovarian cancer (EOC) is the ﬁfth
leading cause of cancer deaths and the third among gynecolog-
ical cancer worldwide (Ferlay et al., 2010). It is well known
that pregnancy and use of oral contraceptives can reduce the
risk of EOC development (Tiedemann, 2000; Clow et al.,
2002). Additionally, it has been reported that EOC is absent
in animal species where seasonal ovulation and multiple preg-
nancies take place. Suppression of ovulation and steroid pro-
duction by the pre-ovulatory follicles are main signiﬁcant
alterations that occur within the ovary during pregnancy.
OC is highly associated with high exposure to gonadotropins.
This is evident because a research on the use of ovulation
inducing treatments by infertile women showed a direct pro-
portionality between the number of OC cases and the ovula-
tion induction use (Rizzuto et al., 2013). At menopause, it is
evident that gonadotropins are released in high quantities
and hence causing the high risk of cancer in post-menopause
females (Leung and Choi, 2007). Both the follicle stimulating
(FSH) and luteinizing hormones (LH) are very important tro-
phic factors especially for the survival and proliferation of the
follicular somatic cells and aiding in the cyclic recruitment of
the antral follicles (Zhang et al., 2013). On the other hand, the-
ory states that OC is triggered by an increase of estrogen pro-
duction that triggers OSE proliferation (Baby and Bartlewski,
2011). Steroid hormones have been implicated in the etiology
of some EOC. Expression of estrogen (ER), progesterone
(PR) and androgen (AR) receptors has been reported in hu-
man EOC (Akahira et al., 2002; Hamilton et al., 1981).
According to Fortune (1994) senescent ovary, like the one
during pregnancy or postnatal period, maintains oocytes in
‘‘resting’’ or primordial follicles (Fortune, 1994). Growing
follicles either ovulate to release oocytes for fertilization, ordegenerate through into atresia. Differentiated follicles also
provide steroidal hormones to maintain the ovarian cycle
and prepare uterus for implant, and corpus luteum (CL) pro-
duces hormones for establishing and maintaining pregnancy.
Gonadotropins and estrogens are vital for maintaining ovarian
cycle until antral stage just before ovulation.
The objective of this study is to determine hormonal ﬂuctu-
ation namely steroids and gonadotropins during pregnancy. A
second purpose of our investigations is to examine the expres-
sion of steroid receptors in OSE cells at different stages of
pregnancy.
2. Materials and methods
2.1. Animals
Adult female rats weighing 250–300 g were obtained from the
central animal house at the King Fahd Medical and Research
Centre (KFMRC) and maintained under controlled
conditions of temperature (23–27 C) and lighting (lights on
05:00–19:00 h). Vaginal smears were examined daily and on
the day of estrous. Pregnancy was induced in the animals by
transferring 1 female rat to the cage of a single male rat and
left overnight. Mating was veriﬁed the next morning by the
presence of vaginal plug in the vaginal smear; this was
designated as Day 1 of pregnancy. Rats were bled 1 ml by
retro-orbital plexus puncture under light diethyl-ether
anesthesia. Blood samples were centrifuged immediately after
collection. Plasma was separated and stored at 20 C until
assayed for, estradiol, progesterone, LH and FSH hormones.
All experimental procedures were approved by the animal
ethics committee.
2.2. Sample collection
Ovaries from estrus and pregnant animals were collected. The
ovaries were gently handled during collection to avoid cell loss
by excessive handling as the OSE is a very fragile layer. The
ovaries were classiﬁed according to the reproductive status of
the rats: ovaries from estrus rats (n= 5) and ovaries from
pregnant rats (n= 15). This last group was further sub-divided
into three groups based on the stage of pregnancy, the three
groups were as follows; ovaries in early gestation (day 7)
(n= 5) and ovaries in mid gestation (day 14) (n= 5) and late
gestation (day 21) (n= 5). Pregnancy was conﬁrmed by
abdominal palpation. Full term pregnancies range from
21–22 days. Ovarian tissue samples from pregnant animals
and estrous animals were collected alongside material from.
2.3. Histological methods
Ovarian tissues were ﬁxed in Bouin’s, dehydrated in graded
alcohols and embedded in parafﬁn, and sectioned serially at
6 lm and mounted on Super Frost plus microscope slides
(VWR International Ltd., Leicestershire, UK) and left to dry
overnight at 37 C.
2.4. PR and ERa immunohisthemistry
The effect of the reproductive stage (estrous or pregnancy) on
















































Figure 1 Histogram representing plasma concentrations of
estradiol (a) and progesterone (b) at estrous cycle (n= 5), day 7
pregnancy (n= 5), day 14 pregnancy (n= 5) and day 21
pregnancy (n= 5). Different letters above the bars indicate
statistically differences between groups among groups
(P 6 0.05). Values are means of concentrations ±MSE.
234 S.Y. Saddickusing immunohisthemistry (IHC) methods. Sections were
de-waxed in xylene, and hydrated in descending grades of alco-
hol to distilled water, and followed by double washing with
phosphate buffer saline (PBS). A heat-induced epitope retrie-
val method was performed (antigen retrieval) by microwaving
(high power at 800 W) the sections in a 0.01 M citrate buffer
(pH 6.0). Endogenous peroxidase activity was inactivated
through incubation with 3 percent hydrogen peroxide in meth-
anol. Sections were incubated with monoclonal mouse anti-hu-
man estrogen receptor a clone 1D5 (Dako Autostainer/
Autostainer Plus-Code IS657) to detect ER and with monoclo-
nal mouse anti-human progesterone receptor clone PgR 636
(Dako/FLEX Code IR068) to detect PR. Sections were
incubated overnight with the primary antibody at 4 C. The
NovoLink polymer detection system (RE7 150-K, Novastra
Laboratories Ltd., UK) was used for visualization. Sections
were incubated with protein blk for 5 min, followed by an
overnight incubation with the primary antibody (1:2000 at
4 C). After being washed with PBS, a post-primary blk was
performed for 30 min. Sections were incubated with the Nov-
oLink polymer solution for 30 min, and then washed with
PBS. Peroxidase activity was developed using a DAB solution
for 5 min. Sections were counterstained using hematoxylin
stain. Optimization of antibody was necessary to enhance the
permeability to the tissue. Antibody incubation time and tem-
perature were adjusted to overnight at 4 C instead of 60 min
at 37 C. As a negative control, the blking solution was left
on the sections instead of the primary antibody to insure the
purity of the staining procedure. Samples of breast cancer were
used as a positive control. At each run of IHC, a set of slides
including sections from all groups of study plus negative and
positive control were run together under the same experimen-
tal condition. Two sections from each ovary were selected
randomly for the analysis.
2.5. Steroids and gonadotropins determination
Concentrations of progesterone, estradiol, FSH and LH in
peripheral plasma were determined in all participants using
ELISA kits. For estradiol determination, the Estradiol
ELISA kit (catalog no. 582251; Cayman Chemical Co.,
Ann Arbor, MI) was used. For progesterone determination,
the DHT ELISA kit form BioVendor (catalog no. RCAN-
DHT-280R) was used. For FSH determination, the RAT
FSH ELISA kit form BioVendor (catalog no. RSHAKRFS-
010R) was used. For LH determination, the RAT LH ELISA
kit form BioVendor (catalog no. RSHAKRLH-010SR) was
used. For all hormones the standard protocols provided by the
manufacturers were followed using undiluted, 1:50, or 1:150
dilutions.
2.6. Statistics
Student’s t test was used to test the signiﬁcance of difference
between two means. Analysis of variance was carried out
when more than two means were compared and the signiﬁ-
cance of the difference between means was determined by
Duncan’s multiple range tests. Differences were considered
to be signiﬁcant at P 6 0.05. Analysis was done using
Minitab version 15.3. Results
3.1. Estradiol and Progesterone concentrations during the
estrous cycle and pregnancy
During a rat’s estrous cycle and pregnancy period, levels of
estradiol and progesterone ﬂuctuated as shown in Fig. 1
(a and b). The concentrations of estradiol on day 7 of preg-
nancy (62 pg/ml) were similar to the levels measured at estrous
(53 pg/ml). Then on day 14 of pregnancy a signiﬁcant increase
in the concentration of estradiol was observed (152 pg/ml).
Further increased was noticed on day 21 (288 pg/ml), the level
of estradiol surged signiﬁcantly and progressively up to term.
The estradiol peak during pregnancy was higher than its peak
during estrous (Fig. 1-a).
As measured by the radioimmunoassay technique, proges-
terone concentrations during all stages of pregnancy signiﬁ-
cantly exceeded estrous values. On day 7 of pregnancy,
progesterone values increased sharply to 131 ng/ml, highest
levels were recorded during the second week of pregnancy on
day 14 (202 ng/ml) followed by a gradual decrease in the levels
on day 21 (124 ng/ml) but values remain above estrous values
(5 ng/ml). The concentrations of progesterone decrease gradu-






























Figure 3 Histogram representing percentage of ER at estrous
cycle (n= 5), day 7 pregnancy (n= 5), day 14 pregnancy (n= 5)
and day 21 pregnancy (n= 5). Different letters above the bars
indicate statistically differences between groups among groups
(P 6 0.05). Values are means of concentrations ±MSE.
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pregnancy
FSH and LH levels remained low throughout pregnancy com-
pared to the estrous values (117 and 86 ng/ml) respectively. On
day 7 of pregnancy, FSH concentration decreased signiﬁcantly
(78 ng/ml) onward, the levels remained steady low as recorded
on day 14 (81 ng/ml). A slight increase in FSH concentration
was recorded on day 21 (112 ng/ml) (Fig. 2-a).
During pregnancy, LH levels were signiﬁcantly lower than
the estrous levels (86 ng/ml). On day 7 of pregnancy, the value
of LH hormone was 46 ng/ml followed with sharp decreasing
on day 14 (16 ng/ml). An unexpected rise in LH value was
reported on day 21 (47 ng/ml) which was continuous until
parturition (Fig. 2-b).
3.3. Expression of Estrogen a receptor and progesterone
receptor
The ovary of estrous rat showed low levels of ERa expression,
3.5% of OSE nuclei were stained with DAB brown color
(Fig. 3). Generally the percentage of OSE cells staining positive
for ERa was relatively low in the pregnant rats. ERa positive
cells were absent on day 7 and 14 of pregnancy, only day 21
recorded a very low percentage of immunostaining (0.5%)












































Figure 2 Histogram representing plasma concentrations of FSH
(a) and LH (b) at estrous cycle (n= 5), day 7 pregnancy (n= 5),
day 14 pregnancy (n= 5) and day 21 pregnancy (n= 5). Different
letters above the bars indicate statistically differences between
groups among groups (P 6 0.05). Values are means of
concentrations ±MSE.immunostaining of PR was not observed within the nuclei of
OSE cells in all groups of study, PR was absent in the rat
OSE cells (Fig. 5).4. Discussion
Multiple pregnancies play a signiﬁcant role in reducing
chances of OC. Recent research shows that breastfeeding
and pregnancy reduces the risk of getting OC. Pregnancy is
one of the factors which suppress ovulation process. Ceaseless
ovulation hypothesis insinuates that recurring monthly
menstrual sequence of epithelium trauma and successive
replacement of worn out tissues after ovulation increases the
exposure of the OSE to various risk factors including genetic
instabilities (Fathalla, 1971). On the other hand, theory states
that OC is triggered by an increase of estrogen production and
the proliferation of ovarian surface epithelium (Baby and
Bartlewski, 2011).
The physiology of OSE cells is of interest since the majority
of female OCs originates in these cells (Vanderhyden et al.,
2003). Several studies have investigated the dynamic of follic-
ular growth at pregnancy but none had focused on the role
of pregnancy as a protective factor against OC. The current
study was designed to determine hormonal ﬂuctuation namely
steroids and gonadotropins during pregnancy and to examine
the expression of steroid receptors in OSE cells at different
stages of pregnancy.
During pregnancy several factors, notably high steroidal
hormones produced in feto-placental unit and CL, may retard
follicle development, and suppress OSE proliferation. Accord-
ing to a recent ‘‘gonadotropin theory’’, the expression of LH
and FSH receptors on the surface of OSE cells is a direct re-
sponse of gonadotropins (Choi et al., 2007). Most likely the
hormone-stimulated receptors trigger the localized prolifera-
tion events. Besides, these receptors also initiate the oncogenic
pathways. OSE cell differentiation was investigated in the
presence of exogenously supplemented estrogens and proges-
terone (Ho, 2003; Laviolette et al., 2010). In the current study,
determination of the levels of steroids and gonadotropins in
the plasma of pregnant rats has been made. The pattern of
m0 µ525 µm(a) (b)
Figure 4 Photomicrographs showing ERa expression within OSE cells at estrous (a) and on day 14 of pregnancy. (b) Red arrow shows a
positive staining (brown color).
m0 µ5m0 µ5(a) (b)
Figure 5 Photomicrographs showing PR expression within OSE cells at estrous (a) and on day 14 of pregnancy. (b) Red arrow shows a
negative staining (blue color).
236 S.Y. Saddickhormone ﬂuctuation during pregnancy reported here is consis-
tent with previous studies (Kallen, 2004).
In this study, estradiol values were generally low except at
the end of pregnancy. At the ﬁrst week of pregnancy on day
7, the levels of estradiol rose then followed by a steady decline
until the middle stage of pregnancy and then continued to rise
gradually toward the end of term.
In this study, FSH and LH levels remained low throughout
the pregnancy period except for some instances like on day 21.
Low concentrations of plasma LH during pregnancy may con-
tribute to the suppression of follicular maturation during this
time. Gonadotropins like LH, FSH and human chorionic
gonadotropin (hCG) are the other hormones regulating OSE
proliferation and transformation into cancerous cells (Trabert
et al., 2013; Yang et al., 2013). The levels of FSH and LH
which are required for ovulation may be suppressed by the
high concentration of progesterone. FSH is considered to be
the most important hormone controlling folliculogenesis,
especially at later stages of follicle growth (Chafﬁn and
Vandevoort, 2013). According to theory, high level of FSH
and LH is known to wear the epithelium, and hence responsi-
ble for OC. Several studies revealed that gonadotropins treat-
ment may increase OSE proliferation in different animal
models (Hilliard et al., 2013; Stewart et al., 2004). The results
of this study suggest that pregnancy may protect from OC by
decreasing the levels of gonadotropins throughout pregnancy
and therefore reduce the exposure of OSE cells to FSH and
LH. However, the role of gonadotropins on OSE cells is not
fully characterized.In conclusion, these results may suggest that progesterone
effect during pregnancy seems to be overriding the positive
effect of estrogens on OSE cells. High progesterone levels
may have a direct negative effect on gonadotropin production
and thereby it might inhibit events leading to both follicular
development and OSE proliferation. Understanding the fac-
tors affecting OSE proliferation may help elucidating the
mechanism(s) of assisted diseases such as ovarian cancer.Acknowledgment
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